:max_bytes(150000):strip_icc()/06-StressTestinganETFPortfolio-06d4f34a80594f06b4dee79a6fa2fc4b.png?#)
:max_bytes(150000):strip_icc()/02_Beyond60_40BuildingaMulti-AssetETFPortfolioforStructuralUncertainty-58ddfdc3daa042ec84bdb410fc1a652e.png?#)
4 Pharma stocks that can benefit from the $95 Billion anti-obesity drug market
The global market for GLP-1-based weight loss drugs is set for explosive growth, expected to rise from USD 13.84 billion in 2024 to USD 48.84 billion by 2030, reflecting a CAGR of 18.5 percent, according to Grand View Research.
The global market for GLP-1-based weight loss drugs is set for explosive growth, expected to rise from USD 13.84 billion in 2024 to USD 48.84 billion by 2030, reflecting a CAGR of 18.5 percent, according to Grand View Research.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
